Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Net Asset Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Net Asset Quality Index of 76.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.88 Billion minus total liabilities of CN¥1.16 Billion yields net assets of CN¥3.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Sichuan Huiyu Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sichuan Huiyu Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2017–2024)
This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 76.3%, representing net assets of CN¥3.72 Billion against total assets of CN¥4.88 Billion CNY. For live market cap and overall valuation, see Sichuan Huiyu Pharmaceutical Co Ltd market cap and net worth.
Annual Net Asset Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Sichuan Huiyu Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 76.9% | CN¥3.97 Billion | CN¥5.17 Billion | CN¥1.19 Billion | ▼ -3.6 pp |
| 2023 | 80.6% | CN¥3.77 Billion | CN¥4.69 Billion | CN¥911.22 Million | ▼ -6.4 pp |
| 2022 | 86.9% | CN¥3.72 Billion | CN¥4.28 Billion | CN¥558.44 Million | ▲ +0.8 pp |
| 2021 | 86.2% | CN¥3.56 Billion | CN¥4.13 Billion | CN¥571.01 Million | ▲ +24.2 pp |
| 2020 | 62.0% | CN¥751.48 Million | CN¥1.21 Billion | CN¥461.26 Million | ▲ +14.4 pp |
| 2019 | 47.5% | CN¥408.65 Million | CN¥859.98 Million | CN¥451.33 Million | ▲ +91.9 pp |
| 2018 | -44.4% | CN¥-150.70 Million | CN¥339.31 Million | CN¥490.02 Million | ▲ +33.9 pp |
| 2017 | -78.3% | CN¥-185.32 Million | CN¥236.61 Million | CN¥421.94 Million | — |